Abbildung 18: Nebenwirkungen
Addresses most common IFN-related adverse events. Pre-T is pre-Transition rate Post-T is post-Transition rate Points to note: new onset events very uncommon on 44/44 indicating that most patients who develop IFN-related Aes do so early on; increase in ISR for 30/44 is expected based on change in route of administration; numbers of new LFT and WBC events is consistent with dose effect of IFN on these events; number of new FLS is quite low compared to initiation of 30mcg though still greater than new FLS for 44/44 group.